Morphometric evaluation of neurophysin-immunoreactivity in the human brain: pronounced inter-individual variability and evidence for altered staining patterns in schizophrenia
- PMID: 8228177
Morphometric evaluation of neurophysin-immunoreactivity in the human brain: pronounced inter-individual variability and evidence for altered staining patterns in schizophrenia
Abstract
The neurohypophyseal peptides vasopressin and oxytocin have a variety of well documented behavioural effects. Accordingly, terminals and receptors that respectively contain or bind these peptides have been identified throughout the central nervous system (CNS) in experimental animals. In this study we have mapped the distribution of neurophysin I and II-immunoreactive structures in the human CNS. Neurophysins are portions of the precursor proteins for vasopressin and oxytocin, and are found specifically in structures that contain these peptides. In addition, we have quantitatively compared neurophysin neurons and fibers in the brains of individuals with no history of neurologic or psychiatric abnormality, and in brains of patients dying with psychotic illness categorized as schizophrenia. These latter brains were collected prior to the advent of pharmacologic treatment and were available from the Vogt collection. Our findings show wide variations of morphometric values obtained for neurophysin-stained structures in different CNS regions in normal subjects, but provide evidence for abnormal values in certain brain areas in untreated schizophrenia, in the hypothalamic paraventricular nucleus, internal pallidal segment and substantia nigra. These findings suggest that the function of vasopressin and/or oxytocin may be disturbed in these brain regions in schizophrenia. Further investigation will be required to establish whether these differences contribute to, or are a consequence of the disease mechanism.
Similar articles
-
Beacon-like/ubiquitin-5-like immunoreactivity is highly expressed in human hypothalamus and increased in haloperidol-treated schizophrenics and a rat model of schizophrenia.Psychoneuroendocrinology. 2008 Apr;33(3):340-51. doi: 10.1016/j.psyneuen.2007.12.002. Epub 2008 Jan 8. Psychoneuroendocrinology. 2008. PMID: 18191906
-
[Role of the neurohypophysis in psychological stress].Encephale. 2001 May-Jun;27(3):245-59. Encephale. 2001. PMID: 11488255 Review. French.
-
Developmental organization of neurophysin neurons in the human brain.J Comp Neurol. 1997 Sep 1;385(3):477-89. J Comp Neurol. 1997. PMID: 9300772
-
Central nervous system effects of the neurohypophyseal hormones and related peptides.Front Neuroendocrinol. 1993 Oct;14(4):251-302. doi: 10.1006/frne.1993.1009. Front Neuroendocrinol. 1993. PMID: 8258377 Review.
-
Immunohistochemistry of vasopressin, oxytocin and neurophysin in the hypothalamus and extrahypothalamic regions of the human and primate brain.Acta Histochem Suppl. 1981;24:79-95. Acta Histochem Suppl. 1981. PMID: 6785843
Cited by
-
Cytoarchitectonic Maps of the Human Metathalamus in 3D Space.Front Neuroanat. 2022 Mar 8;16:837485. doi: 10.3389/fnana.2022.837485. eCollection 2022. Front Neuroanat. 2022. PMID: 35350721 Free PMC article.
-
Dysregulation of Hypothalamic Gene Expression and the Oxytocinergic System by Soybean Oil Diets in Male Mice.Endocrinology. 2020 Feb 1;161(2):bqz044. doi: 10.1210/endocr/bqz044. Endocrinology. 2020. PMID: 31912136 Free PMC article.
-
In vivo Probabilistic Structural Atlas of the Inferior and Superior Colliculi, Medial and Lateral Geniculate Nuclei and Superior Olivary Complex in Humans Based on 7 Tesla MRI.Front Neurosci. 2019 Aug 7;13:764. doi: 10.3389/fnins.2019.00764. eCollection 2019. Front Neurosci. 2019. PMID: 31440122 Free PMC article.
-
Expression of vasopressin mRNA in the hypothalamus of individuals with a diagnosis of schizophrenia.Brain Behav. 2019 Sep;9(9):e01355. doi: 10.1002/brb3.1355. Epub 2019 Jul 13. Brain Behav. 2019. PMID: 31339235 Free PMC article.
-
Insulin-regulated aminopeptidase immunoreactivity is abundantly present in human hypothalamus and posterior pituitary gland, with reduced expression in paraventricular and suprachiasmatic neurons in chronic schizophrenia.Eur Arch Psychiatry Clin Neurosci. 2017 Aug;267(5):427-443. doi: 10.1007/s00406-016-0757-7. Epub 2016 Dec 29. Eur Arch Psychiatry Clin Neurosci. 2017. PMID: 28035472